Skip to main content
Veterinary Medicines

VACSINCEL SOLUCION INYECTABLE PARA CERDAS

Authorised
  • Gonadotropin releasing factor analogue diphtheria toxoid conjugate

Product identification

Medicine name:
VACSINCEL SOLUCION INYECTABLE PARA CERDAS
Active substance:
  • Gonadotropin releasing factor analogue diphtheria toxoid conjugate
Target species:
  • Pig (female)
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Gonadotropin releasing factor analogue diphtheria toxoid conjugate
    300.00
    microgram(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Pig (female)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG03XA91
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Spain S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
  • Sciensano
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 3009 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 29/11/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."